Compare Advanced Drainage Systems Inc (WMS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Advanced Drainage Systems Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Advanced Drainage Systems Inc trades at $131.63 (market cap $9.94B), while State Street SPDR S&P Biotech ETF trades at $159.33. The key difference: Advanced Drainage Systems Inc pays a 0.61% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Advanced Drainage Systems Inc nearer its low. Which is the better fit depends on your goals.
| WMS | XBI | |
|---|---|---|
Market Cap | $9.94B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $175.38 | $169.55 |
52-Week Low | $129.50 | $93.43 |
Enterprise Value | $11.54B | — |
Dividend Yield | 0.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WMS trades at $133.67, down 1.54% today, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news highlights institutional buying and positive analyst coverage, though technical indicators show near-term pressure.
The outlook is mixed: analyst consensus targets $191.50, implying upside, but near-term technical weakness and a projected net cash outflow in 2026 pose risks. Investment appeal hinges on execution of growth initiatives and margin stability amid competitive and macroeconomic headwinds.
XBI (SPDR S&P Biotech ETF) trades at $161.97, down 1.12% on the day, with a bearish technical signal overall despite bullish moving averages. The ETF holds over 150 biotech companies, benefiting from strong M&A activity and positive clinical catalysts, though key financial ratios are not applicable for the fund structure. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook remains cautiously optimistic given sector tailwinds, but high volatility and concentration in small-cap biotech pose risks. The single analyst covering the ETF maintains a Hold rating, reflecting a neutral stance amid the sector's rally and inherent volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
